Linsin (Nigella sativa)

Nigella sativa contains thymoquinone as its primary bioactive compound, which demonstrates anti-tumor activity through multiple cellular pathways. The seeds also contain nigellone, which blocks calcium channels to inhibit histamine release in respiratory conditions.

Origin & History

Linsin (Nigella sativa) is a herbaceous plant native to Southwest Asia, the Mediterranean region, and North Africa, with seeds containing 27-40% fixed oils and bioactive compounds. The seeds are processed through supercritical fluid extraction, hydrodistillation, or solvent extraction to yield essential oils rich in volatile terpenes and quinones, particularly thymoquinone (33-38%).

Historical & Cultural Context

Nigella sativa has been used as a panacea in global traditional medicine for centuries, spanning Unani, Ayurvedic, and Middle Eastern systems for ailments like asthma, inflammation, and infections. The herb holds significant cultural importance across these traditional medicine systems, though specific historical timelines were not detailed in the research.

Health Benefits

• Anti-tumor effects: Preclinical evidence shows thymoquinone activity against breast, lung, prostate, liver, colon, and pancreatic cancers (preliminary evidence only)
• Respiratory support: Nigellone compound inhibits histamine release in asthma models through calcium channel blockade (animal studies)
• Antioxidant activity: Terpenoids like carvacrol demonstrate antioxidant properties (in-vitro evidence)
• Anti-inflammatory effects: Seed extracts show anti-inflammatory activities (preclinical evidence only)
• Antimicrobial properties: Extract components exhibit antimicrobial actions (laboratory studies only)

How It Works

Thymoquinone modulates multiple signaling pathways including NF-κB, p53, and MAPK to induce apoptosis in cancer cells while inhibiting proliferation and angiogenesis. Nigellone acts as a calcium channel blocker, preventing mast cell degranulation and subsequent histamine release. These compounds also exhibit antioxidant activity by scavenging free radicals and enhancing endogenous antioxidant enzyme systems.

Scientific Research

The research dossier reveals a critical gap: no human clinical trials, RCTs, or meta-analyses with PubMed PMIDs were found in the search results. All available evidence comes from preclinical studies focusing on phytochemical analysis and in-vitro or animal models, highlighting the need for human clinical research.

Clinical Summary

Current evidence for Nigella sativa primarily comes from preclinical animal studies and in vitro research, with limited human clinical data. Animal studies have shown thymoquinone's anti-tumor effects across multiple cancer types including breast, lung, and prostate cancers, though human efficacy remains unestablished. Respiratory studies in asthma models demonstrate histamine inhibition, but controlled human trials are lacking. Sample sizes in existing preliminary human studies are typically small (under 100 participants) with short duration follow-up periods.

Nutritional Profile

{"macronutrients": {"protein": "21g per 100g", "fat": "35g per 100g", "carbohydrates": "44g per 100g", "fiber": "10g per 100g"}, "micronutrients": {"calcium": "931mg per 100g", "iron": "66.36mg per 100g", "magnesium": "385mg per 100g", "zinc": "4.6mg per 100g", "vitamin B1 (thiamine)": "0.4mg per 100g", "vitamin B2 (riboflavin)": "0.11mg per 100g", "vitamin B3 (niacin)": "5.8mg per 100g"}, "bioactive_compounds": {"thymoquinone": "1-2% of the oil", "nigellone": "trace amounts", "carvacrol": "trace amounts"}, "bioavailability_notes": "The bioavailability of thymoquinone can be enhanced when consumed with fats, as it is lipophilic. Minerals like iron and calcium may have reduced absorption due to the presence of phytates."}

Preparation & Dosage

No clinically studied dosage ranges for extracts, powder, or standardized forms are available in the current research. Studies mention thymoquinone as the major active compound but do not specify standardization percentages or dosing protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Boswellia, Green Tea Extract, Quercetin

Safety & Interactions

Nigella sativa is generally well-tolerated in culinary amounts but may cause gastrointestinal upset, skin reactions, or hypoglycemia at therapeutic doses. It may interact with diabetes medications by enhancing hypoglycemic effects and could potentiate anticoagulant drugs. Pregnancy and breastfeeding safety is not established, so use should be avoided during these periods. Individuals with bleeding disorders or scheduled for surgery should discontinue use due to potential anticoagulant effects.